Thalidomide attenuates nitric oxide-driven angiogenesis by interacting with soluble guanylyl cyclase.
Majumder S, Rajaram M, Muley A, Reddy HS, Tamilarasan KP, Kolluru GK, Sinha S, Siamwala JH, Gupta R, Ilavarasan R, Venkataraman S, Sivakumar KC, Anishetty S, Kumar PG, Chatterjee S.
Majumder S, et al. Among authors: tamilarasan kp.
Br J Pharmacol. 2009 Dec;158(7):1720-34. doi: 10.1111/j.1476-5381.2009.00446.x.
Br J Pharmacol. 2009.
PMID: 19912234
Free PMC article.